当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析

和邦生物

(603077)

  

流通市值:181.93亿  总市值:181.93亿
流通股本:88.31亿   总股本:88.31亿

和邦生物(603077)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.40亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1874060.16万元,未分配利润953307.88万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产2922331.82万元,负债1048271.67万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入3,921,052,446.511,725,715,319.778,547,476,550.136,813,692,192.92
营业总成本3,858,427,658.11,693,064,580.468,490,183,101.476,550,036,297.8
其他经营收益
营业利润55,523,080.5420,884,096.69-61,792,560.91260,299,739.07
利润总额54,981,044.4220,644,011.1-65,683,562.06259,501,458.7
净利润40,239,432.367,535,116.9-70,744,609.93195,536,979.04
每股收益
其他综合收益-2,688,512.5314,505,248.27-56,289,225.8-33,076,482.29
综合收益总额37,550,919.8322,040,365.17-127,033,835.73162,460,496.75
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计13,193,620,620.7713,875,476,279.514,003,269,456.6310,828,282,355.32
非流动资产:
非流动资产合计16,029,697,607.1915,969,472,970.5515,646,465,083.2515,147,030,324.6
资产总计29,223,318,227.9629,844,949,250.0529,649,734,539.8825,975,312,679.92
流动负债:
流动负债合计4,266,750,910.084,923,063,854.835,374,508,558.615,762,231,159.4
非流动负债:
非流动负债合计6,215,965,766.056,196,525,475.195,268,707,775.63832,292,622.49
负债合计10,482,716,676.1311,119,589,330.0210,643,216,334.246,594,523,781.89
所有者权益(或股东权益):
归属于母公司股东权益合计18,491,495,319.5618,468,988,158.6518,626,392,431.8718,764,699,737.51
股东权益合计18,740,601,551.8318,725,359,920.0319,006,518,205.6419,380,788,898.03
负债和股东权益合计29,223,318,227.9629,844,949,250.0529,649,734,539.8825,975,312,679.92
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计3,303,361,952.351,663,561,006.737,679,632,279.65,330,288,586.7
经营活动现金流出小计3,157,892,412.981,718,152,415.437,211,700,892.435,467,511,402.22
经营活动产生的现金流量净额145,469,539.37-54,591,408.7467,931,387.17-137,222,815.52
投资活动产生的现金流量:
投资活动现金流入小计118,794,561.4830,851,147.3845,571,519.0324,155,473.91
投资活动现金流出小计542,039,294.86368,932,073.751,432,690,999.8788,665,017.11
投资活动产生的现金流量净额-423,244,733.38-338,080,926.37-1,387,119,480.77-764,509,543.2
筹资活动产生的现金流量:
筹资活动现金流入小计2,757,728,220.332,279,208,350.858,140,310,049.052,869,202,966.79
筹资活动现金流出小计2,476,865,651.661,674,186,984.183,293,099,772.232,501,497,326.9
筹资活动产生的现金流量净额280,862,568.67605,021,366.674,847,210,276.82367,705,639.89
汇率变动对现金及现金等价物的影响-7,911,681.591,784,946.918,709,035.49-4,277,081
现金及现金等价物净增加额-4,824,306.93214,133,978.53,946,731,218.71-538,303,799.83
期末现金及现金等价物余额6,846,738,753.867,065,697,039.296,851,563,060.792,366,528,042.25
补充资料:
现金及现金等价物的净增加额-4,824,306.93-3,946,731,218.71-
TOP↑